Home/VIVUS/John Amos

JA

John Amos

Chief Executive Officer

Therapeutic Areas

Obesity Gastroenterology Metabolic Disorders

VIVUS Pipeline

Drug	Indication	Phase
QSIVA®/QSYMIA®	Chronic Weight Management	Approved
PANCREAZE®	Exocrine Pancreatic Insufficiency (EPI)	Approved

Leadership Team at VIVUS

Santosh T. Varghese, MD

President, Global Pharmaceutical Development & Chief Medical Officer

Senior Vice President & Chief Financial Officer

Chief Strategy Officer

View full VIVUS profile